Style | Citing Format |
---|---|
MLA | Abrehdaritafreshi Z, et al.. "The Role of Mir-29A and Mir-143 on the Anti-Apoptotic Mcl-1/Ciap-2 Genes Expression in Egfr Mutated Non-Small Cell Lung Carcinoma Patients." Biochemical Genetics, vol. , no. , 2024, pp. -. |
APA | Abrehdaritafreshi Z, Arefian E, Rakhshani N, Najafi SMA (2024). The Role of Mir-29A and Mir-143 on the Anti-Apoptotic Mcl-1/Ciap-2 Genes Expression in Egfr Mutated Non-Small Cell Lung Carcinoma Patients. Biochemical Genetics, (), -. |
Chicago | Abrehdaritafreshi Z, Arefian E, Rakhshani N, Najafi SMA. "The Role of Mir-29A and Mir-143 on the Anti-Apoptotic Mcl-1/Ciap-2 Genes Expression in Egfr Mutated Non-Small Cell Lung Carcinoma Patients." Biochemical Genetics , no. (2024): -. |
Harvard | Abrehdaritafreshi Z et al. (2024) 'The Role of Mir-29A and Mir-143 on the Anti-Apoptotic Mcl-1/Ciap-2 Genes Expression in Egfr Mutated Non-Small Cell Lung Carcinoma Patients', Biochemical Genetics, (), pp. -. |
Vancouver | Abrehdaritafreshi Z, Arefian E, Rakhshani N, Najafi SMA. The Role of Mir-29A and Mir-143 on the Anti-Apoptotic Mcl-1/Ciap-2 Genes Expression in Egfr Mutated Non-Small Cell Lung Carcinoma Patients. Biochemical Genetics. 2024;():-. |
BibTex | @article{ author = {Abrehdaritafreshi Z and Arefian E and Rakhshani N and Najafi SMA}, title = {The Role of Mir-29A and Mir-143 on the Anti-Apoptotic Mcl-1/Ciap-2 Genes Expression in Egfr Mutated Non-Small Cell Lung Carcinoma Patients}, journal = {Biochemical Genetics}, volume = {}, number = {}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Abrehdaritafreshi Z AU - Arefian E AU - Rakhshani N AU - Najafi SMA TI - The Role of Mir-29A and Mir-143 on the Anti-Apoptotic Mcl-1/Ciap-2 Genes Expression in Egfr Mutated Non-Small Cell Lung Carcinoma Patients JO - Biochemical Genetics VL - IS - SP - EP - PY - 2024 ER - |